Advances and Challenges in Antiviral Development for Respiratory Viruses
Pathogens · 31.12.2024 · 14 (1) · 20
DOI: 10.3390/pathogens14010020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 31.12.2024. Verfasst von Luis Adrián De Jesús-González und 13 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas 98000, Mexico. Hauptthemen laut MEDLINE: Antiviral Agents, Respiratory Tract Infections. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FUNDACIÓN IMSS, AC.
Abstract (Originalsprache)
The development of antivirals for respiratory viruses has advanced markedly in response to the growing threat of pathogens such as Influenzavirus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2. This article reviews the advances and challenges in this field, highlighting therapeutic strategies that target critical stages of the viral replication cycle, including inhibitors of viral entry, replication, and assembly. In addition, innovative approaches such as inhibiting host cellular proteins to reduce viral resistance and repurposing existing drugs are explored, using advanced bioinformatics tools that optimize the identification of antiviral candidates. The analysis also covers emerging technologies such as nanomedicine and CRISPR gene editing, which promise to improve the stability and efficacy of treatments. While current antivirals offer valuable options, they face challenges such as viral evolution and the need for accessible treatments for vulnerable populations. This article underscores the importance of continued innovation in biotechnology to overcome these limitations and provide safe and effective treatments. Combining traditional and advanced approaches in developing antivirals is essential in order to address respiratory viral diseases that affect global health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas 98000, Mexico.
- Laboratorio de Virología Perinatal y Diseño Molecular de Antígenos y Biomarcadores, Departamento de Inmunobioquímica, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
- Especialidad en Medicina Familiar, Unidad Académica de Medicina Humana y Ciencias de la Salud, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.
- Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar # 4, Servicio de Medicina Familiar, Guadalupe, Zacatecas 98618, Mexico.
- Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.
- Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City 07360, Mexico.
ORCID-Profile: Luis Adrián De Jesús-González, Moisés León-Juárez, Bruno Rivas-Santiago, Manuel Adrián Velázquez-Cervantes, Jonathan Hernández-Castillo, Ximena Hernández-Rodríguez, José Manuel Reyes-Ruíz, Juan Fidel Osuna-Ramos
Förderung
- FUNDACIÓN IMSS, AC
Zitieren
APA
De Jesús-González, L. A., León-Juárez, M., Lira-Hernández, F. I., Rivas-Santiago, B., Velázquez-Cervantes, M. A., Méndez-Delgado, I. M., Macías-Guerrero, D. I., Hernández-Castillo, J., Hernández-Rodríguez, X., Calderón-Sandate, D. N., Mata-Martínez, W. S., Reyes-Ruíz, J. M., Osuna-Ramos, J. F., & García-Herrera, A. C. (2024). Advances and Challenges in Antiviral Development for Respiratory Viruses. Pathogens, 14(1), 20. https://doi.org/10.3390/pathogens14010020
Vancouver
De Jesús-González LA, León-Juárez M, Lira-Hernández FI, Rivas-Santiago B, Velázquez-Cervantes MA, Méndez-Delgado IM, et al. Advances and Challenges in Antiviral Development for Respiratory Viruses. Pathogens. 2024;14(1):20. doi:10.3390/pathogens14010020
BibTeX
@article{DeJessGonzlez2024,
author = {De Jesús-González, Luis Adrián and León-Juárez, Moisés and Lira-Hernández, Flor Itzel and Rivas-Santiago, Bruno and Velázquez-Cervantes, Manuel Adrián and Méndez-Delgado, Iridiana Monserrat and Macías-Guerrero, Daniela Itzel and Hernández-Castillo, Jonathan and Hernández-Rodríguez, Ximena and Calderón-Sandate, Daniela Nahomi and Mata-Martínez, Willy Salvador and Reyes-Ruíz, José Manuel and Osuna-Ramos, Juan Fidel and García-Herrera, Ana Cristina},
title = {Advances and Challenges in Antiviral Development for Respiratory Viruses},
journal = {Pathogens},
year = {2024},
volume = {14},
number = {1},
pages = {20},
doi = {10.3390/pathogens14010020}
}
EUVIMED